REGENXBIO Announces Pricing Of Public Offering Of Common Stock
ROCKVILLE, Md., Jan. 8, 2021 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced the pricing of an underwritten public offering of 4,260,000 shares of its common stock at the price of $47.00 per share before underwriting discounts and commissions. The gross proceeds to REGENXBIO…
Comments Off on REGENXBIO Announces Pricing Of Public Offering Of Common Stock